Cargando…

Efficient Sustained-Release Nanoparticle Delivery System Protects Nigral Neurons in a Toxin Model of Parkinson’s Disease

Parkinson’s disease (PD) is a serious neurodegenerative disease wherein the progressive destruction of dopaminergic neurons results in a series of related movement disorders. Effective oral delivery of anti-Parkinson’s drugs is challenging owing to the blood-brain barrier (BBB) and the limited plasm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qun, Ma, Rui, Liu, Piaoxue, Cheng, Guowang, Yang, Qi, Chen, Xiaojia, Wu, Zhenfeng, Yuan, Dongsheng, Chen, Tongkai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415969/ https://www.ncbi.nlm.nih.gov/pubmed/36015354 http://dx.doi.org/10.3390/pharmaceutics14081731

Ejemplares similares

Polymeric Nanoparticles-Based Brain Delivery with Improved Therapeutic Efficacy of Ginkgolide B in Parkinson’s Disease
por: Zhao, Yuying, et al.
Publicado: (2020)

Height and nigral neuron density in Parkinson’s disease
por: Saari, Laura, et al.
Publicado: (2022)

Exosomes as Smart Nanoplatforms for Diagnosis and Therapy of Cancer
por: Zhao, Yuying, et al.
Publicado: (2021)

Reversing Parkinson Disease Model with in situ Converted Nigral Neurons
por: Qian, Hao, et al.
Publicado: (2020)

Pathophysiological Features of Nigral Dopaminergic Neurons in Animal Models of Parkinson’s Disease
por: Guatteo, Ezia, et al.
Publicado: (2022)

Anti-Parkinsonian Therapy: Strategies for Crossing the Blood–Brain Barrier and Nano-Biological Effects of Nanomaterials
por: Cheng, Guowang, et al.
Publicado: (2022)

Evidence for Gender-Specific Transcriptional Profiles of Nigral Dopamine Neurons in Parkinson Disease
por: Simunovic, Filip, et al.
Publicado: (2010)

Heptachlor induced nigral dopaminergic neuronal loss and Parkinsonism-like movement deficits in mice
por: Hong, Seokheon, et al.
Publicado: (2014)

Nigral Neurons Degenerating in Parkinson's Disease Express the Angiotensin Receptor Type 1 Gene
por: Labandeira‐Garcia, Jose L., et al.
Publicado: (2022)

Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: implications for Parkinson’s disease
por: Ayton, Scott, et al.
Publicado: (2014)

Similarities and differences between nigral and enteric dopaminergic neurons unravel distinctive involvement in Parkinson’s disease
por: Chalazonitis, Alcmène, et al.
Publicado: (2022)

Deficiency in endocannabinoid synthase DAGLB contributes to early onset Parkinsonism and murine nigral dopaminergic neuron dysfunction
por: Liu, Zhenhua, et al.
Publicado: (2022)

Effects of Subthalamic and Nigral Stimulation on Gait Kinematics in Parkinson’s Disease
por: Scholten, Marlieke, et al.
Publicado: (2017)

Impact of simultaneous subthalamic and nigral stimulation on dysphagia in Parkinson’s disease
por: Pflug, Christina, et al.
Publicado: (2020)

Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's Disease
por: Heilman, Patrick L., et al.
Publicado: (2020)

Nigral volume loss in prodromal, early, and moderate Parkinson’s disease
por: Langley, Jason, et al.
Publicado: (2023)

The Neuroprotective Mechanism of Low-Frequency rTMS on Nigral Dopaminergic Neurons of Parkinson's Disease Model Mice
por: Dong, Qiaoyun, et al.
Publicado: (2015)

Ultrasmall Coordination Polymers for Alleviating ROS-Mediated Inflammatory and Realizing Neuroprotection against Parkinson's Disease
por: Cheng, Guowang, et al.
Publicado: (2022)

Amygdalo‐nigral circuit mediates stress‐induced vulnerability to the parkinsonian toxin MPTP
por: Cai, Hongwei, et al.
Publicado: (2023)

Multifunctional Graphene Oxide Nanodelivery Platform for Breast Cancer Treatment
por: Mo, Yousheng, et al.
Publicado: (2022)

Subthalamic and nigral neurons are differentially modulated during parkinsonian gait
por: Gulberti, Alessandro, et al.
Publicado: (2023)

Fast 3 T nigral hyperintensity magnetic resonance imaging in Parkinson’s disease
por: Hernadi, Gabriella, et al.
Publicado: (2021)

The Nigral Coup in Parkinson’s Disease by α-Synuclein and Its Associated Rebels
por: Sian-Hulsmann, Jeswinder, et al.
Publicado: (2021)

Nigral Iron Deposition Is Associated With Levodopa-Induced Dyskinesia in Parkinson’s Disease
por: Song, Tianbin, et al.
Publicado: (2021)

Nigral diffusivity, but not free water, correlates with iron content in Parkinson’s disease
por: Langley, Jason, et al.
Publicado: (2021)

Low plasma serotonin linked to higher nigral iron in Parkinson’s disease
por: Jellen, Leslie C., et al.
Publicado: (2021)

Robust boron nanoplatform provokes potent tumoricidal activities via inhibiting heat shock protein
por: Zhao, Yuying, et al.
Publicado: (2022)

Epothilone B Benefits Nigral Dopaminergic Neurons by Attenuating Microglia Activation in the 6-Hydroxydopamine Lesion Mouse Model of Parkinson’s Disease
por: Yu, Zhongyuan, et al.
Publicado: (2018)

Is there a special relationship between complex I activity and nigral neuronal loss in Parkinson’s disease? A critical reappraisal
por: Subrahmanian, Nitya, et al.
Publicado: (2021)

Comparison of Shod and Unshod Gait in Patients With Parkinson's Disease With Subthalamic and Nigral Stimulation
por: Horn, Martin A., et al.
Publicado: (2022)

Nigral neuropathology of Parkinson’s motor subtypes coincide with circuitopathies: a scoping review
por: Boonstra, Jackson Tyler, et al.
Publicado: (2022)

Disentangling nigral and putaminal contribution to motor impairment and levodopa response in Parkinson’s disease
por: Schröter, Nils, et al.
Publicado: (2022)

Nitrated α–Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons
por: Benner, Eric J., et al.
Publicado: (2008)

Glutathione depletion and overproduction both initiate degeneration of nigral dopaminergic neurons
por: Garrido, Manuel, et al.
Publicado: (2010)

Application of flavonoids for the protection of nigral dopaminergic neurons from oxidative stress
por: Kim, Sang Ryong
Publicado: (2020)

Upregulation of neuronal astrocyte elevated gene-1 protects nigral dopaminergic neurons in vivo
por: Leem, Eunju, et al.
Publicado: (2018)

Neurotensin-polyplex-mediated brain-derived neurotrophic factor gene delivery into nigral dopamine neurons prevents nigrostriatal degeneration in a rat model of early Parkinson’s disease
por: Hernandez-Chan, Nancy G., et al.
Publicado: (2015)

Nigral Iron Deposition Influences Disease Severity by Modulating the Effect of Parkinson’s Disease on Brain Networks
por: Wen, Jiaqi, et al.
Publicado: (2022)

Nigral Iron Elevation Is an Invariable Feature of Parkinson's Disease and Is a Sufficient Cause of Neurodegeneration
por: Ayton, Scott, et al.
Publicado: (2014)

Serum Uric Acid and Nigral Iron Deposition in Parkinson’s Disease: A Pilot Study
por: Kim, Tae-Hyoung, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cjnrr213aia9r70vvopnivmmut